Details of Disease

General Information of Disease (ID: DIS4R0UE)

Disease Name Traveler's diarrhea
Synonyms Pica eating disorder; Pica
Disease Class ME05: Bowel habit change
Definition An eating disorder characterized by the persistent eating of nonnutritive substances such as clay or soil; this behavior must be inappropriate to the level of the individual's development.
Disease Hierarchy
DISVGXN0: Eating disorder
DIS4R0UE: Traveler's diarrhea
ICD Code
ICD-11
ICD-11: ME05.1
ICD-9
ICD-9: 001-139, 787.91
Expand ICD-9
001,002,003,004,005,006,007,008,009,010,011,012,013,014,015,016,017,018,019,020,021,022,023,024,025,026,027,028,029,030,031,032,033,034,035,036,037,038,039,040,041,042,043,044,045,046,047,048,049,050,051,052,053,054,055,056,057,058,059,060,061,062,063,064,065,066,067,068,069,070,071,072,073,074,075,076,077,078,079,080,081,082,083,084,085,086,087,088,089,090,091,092,093,094,095,096,097,098,099,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133,134,135,136,137,138,139,787.91
Disease Identifiers
MONDO ID
MONDO_0001441
MESH ID
D010842
UMLS CUI
C0031873
MedGen ID
45917
HPO ID
HP:0011856
SNOMED CT ID
14077003

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 4 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Ciprofloxacin XR DM2NLS9 Approved Small molecular drug [1]
Loperamide DMOJZQ9 Approved Small molecular drug [2]
Norfloxacin DMIZ6W2 Approved Small molecular drug [3]
Ofloxacin DM0VQN3 Approved Small molecular drug [4]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 2 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
ACAM-Cdiff DMH5LHV Phase 2 Vaccine [5]
LMN-101 DM0AQ3D Phase 2 NA [6]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 1 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
DEAF1 OTCLX3ZW Strong Genetic Variation [7]
------------------------------------------------------------------------------------

References

1 A standard database for drug repositioning. Sci Data. 2017 Mar 14;4:170029.
2 Loperamide FDA Label
3 Norfloxacin FDA Label
4 Ofloxacin FDA Label
5 ClinicalTrials.gov (NCT00772343) Study of a Clostridium Difficile Toxoid Vaccine (ACAM-CDIFF in Subjects With Clostridium Difficile Infection. U.S. National Institutes of Health.
6 ClinicalTrials.gov (NCT04182490) A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Single Dose Regimen Study of LMN-101 in Healthy Volunteers Challenged With Campylobacter Jejuni. U.S.National Institutes of Health.
7 Exome analysis of Smith-Magenis-like syndrome cohort identifies de novo likely pathogenic variants. Hum Genet. 2017 Apr;136(4):409-420. doi: 10.1007/s00439-017-1767-x. Epub 2017 Feb 17.